N | (%) | |
---|---|---|
Year of diagnosis | ||
1989 | 231 | 23.6 |
1990 | 207 | 21.1 |
1991 | 182 | 18.6 |
1992 | 189 | 19.3 |
1993 | 170 | 17.4 |
Metastases following surgery | ||
Yes | 264 | 27.0 |
No | 715 | 73.0 |
Age at diagnosis | ||
≤ 40 years | 76 | 7.8 |
> 40 years | 903 | 92.2 |
SBR Grade | ||
Grade I | 275 | 28.1 |
Grade II | 444 | 45.3 |
Grade III | 260 | 26.6 |
Tumor size | ||
≤ 20 mm | 753 | 76.9 |
> 20 mm | 226 | 23.1 |
Lymph node involvement | ||
No | 554 | 56.6 |
Yes | 425 | 43.4 |
Peritumoral vascular invasion | ||
No | 700 | 71.5 |
Yes | 279 | 28.5 |
Hormone Receptor status | ||
Both ER- and PR- | 178 | 18.2 |
At least ER+ or PR+ | 801 | 81.8 |
Her2 status | ||
Positive | 100 | 10.2 |
Negative | 879 | 89.8 |
Mib1 status | ||
Negative | 691 | 70.6 |
Positive | 288 | 29.4 |